ES2038681T3 - Procedimiento de obtencion de la timidina quinasa de tipo fetal purificada. - Google Patents

Procedimiento de obtencion de la timidina quinasa de tipo fetal purificada.

Info

Publication number
ES2038681T3
ES2038681T3 ES198787401729T ES87401729T ES2038681T3 ES 2038681 T3 ES2038681 T3 ES 2038681T3 ES 198787401729 T ES198787401729 T ES 198787401729T ES 87401729 T ES87401729 T ES 87401729T ES 2038681 T3 ES2038681 T3 ES 2038681T3
Authority
ES
Spain
Prior art keywords
procedure
thymidine kinase
obtaining purified
fetal type
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787401729T
Other languages
English (en)
Spanish (es)
Inventor
Pierre Nicolas Jouan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRES DEBAT SA
Original Assignee
LABORATOIRES DEBAT SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LABORATOIRES DEBAT SA filed Critical LABORATOIRES DEBAT SA
Application granted granted Critical
Publication of ES2038681T3 publication Critical patent/ES2038681T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
ES198787401729T 1986-07-31 1987-07-24 Procedimiento de obtencion de la timidina quinasa de tipo fetal purificada. Expired - Lifetime ES2038681T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8611101A FR2602242B1 (fr) 1986-07-31 1986-07-31 Thymidine kinase de type foetal purifiee

Publications (1)

Publication Number Publication Date
ES2038681T3 true ES2038681T3 (es) 1993-08-01

Family

ID=9337917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787401729T Expired - Lifetime ES2038681T3 (es) 1986-07-31 1987-07-24 Procedimiento de obtencion de la timidina quinasa de tipo fetal purificada.

Country Status (14)

Country Link
EP (1) EP0255431B1 (OSRAM)
JP (1) JPS6359886A (OSRAM)
CN (1) CN87105215A (OSRAM)
AT (1) ATE68821T1 (OSRAM)
AU (1) AU594486B2 (OSRAM)
DE (1) DE3774025D1 (OSRAM)
DK (1) DK387387A (OSRAM)
ES (1) ES2038681T3 (OSRAM)
FR (1) FR2602242B1 (OSRAM)
GR (1) GR3003416T3 (OSRAM)
IE (1) IE61237B1 (OSRAM)
NZ (1) NZ221246A (OSRAM)
PT (1) PT85406B (OSRAM)
ZA (1) ZA875378B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1142991A3 (en) * 1993-08-06 2003-03-12 Brigham Young University Technology Transfer Office Monoclonal antibodies to thymidine kinase isozymes
SE9401380D0 (sv) * 1994-04-22 1994-04-22 Sven Skog Ny celltillväxt-relaterad peptid och användning därav
CN1301821A (zh) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 一种新的多肽——胸腺嘧啶核苷酸激酶11和编码这种多肽的多核苷酸
US7311906B2 (en) 2004-04-30 2007-12-25 Brigham Young University Anti-viral activity of an anti-thymidine kinase monoclonal antibody
US7837998B2 (en) 2004-05-21 2010-11-23 Nathaniel Lallatin Anti-cancer activity of an anti-thymidine kinase monoclonal antibody
US8551486B2 (en) 2004-05-21 2013-10-08 Savoy Pharmaceuticals, Inc. Monoclonal antibodies to human thymidine kinase to treat cancer
WO2011082345A2 (en) 2009-12-30 2011-07-07 Brigham Young University Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2028588A1 (de) * 1970-06-10 1971-12-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur Gewinnung von Thymidin-Kinase

Also Published As

Publication number Publication date
NZ221246A (en) 1991-05-28
GR3003416T3 (en) 1993-02-17
IE61237B1 (en) 1994-10-19
PT85406A (fr) 1987-08-01
JPS6359886A (ja) 1988-03-15
DE3774025D1 (de) 1991-11-28
EP0255431A1 (fr) 1988-02-03
CN87105215A (zh) 1988-02-24
JPH0438392B2 (OSRAM) 1992-06-24
EP0255431B1 (fr) 1991-10-23
FR2602242A1 (fr) 1988-02-05
ATE68821T1 (de) 1991-11-15
ZA875378B (en) 1988-01-29
IE872064L (en) 1988-01-31
PT85406B (pt) 1990-04-30
DK387387D0 (da) 1987-07-24
FR2602242B1 (fr) 1989-05-26
AU7607587A (en) 1988-02-04
DK387387A (da) 1988-02-01
AU594486B2 (en) 1990-03-08

Similar Documents

Publication Publication Date Title
ES2098140T3 (es) Liosferas que contienen gonadotropina.
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
ES2188586T3 (es) Utilizacion de inhibidores del complemento para la preparacion de un medicamento para la profilaxis y terapia de enfermedades inflamatorias intestinales y de la piel, asi como purpura.
GT199900054A (es) Uso de dihidropirimidinas como medicamento y nuevas sustancis. as.
ES2052629T3 (es) Pirazolo(3,4-d)piridinas, procedimiento para su preparacion y utilizacion como medicamentos.
ES2082755T3 (es) Derivados de acido 3-desmetil-mevalonico, procedimiento para su preparacion, preparados farmaceuticos a base de estos compuestos, su utilizacion asi como productos intermedios.
BR0307294A (pt) ésteres de ácido fluorenocarboxìlico, processo para sua preparação bem como seu uso como medicamento
ES2145818T3 (es) Utilizacion de la (s)-(-)-alfa-etil-2-oxo-1-pirrolidin-acetamida para la preparacion de medicamentos destinados al tratamiento de la ansiedad.
ES2038681T3 (es) Procedimiento de obtencion de la timidina quinasa de tipo fetal purificada.
FR2363556A1 (fr) Nouvelles phenylethylamines, leur preparation et leur utilisation en tant que medicaments
ES2097887T3 (es) Polimero de carboxivinilo con viscosidad newtoniana.
ES2096973T3 (es) Fosfazenos que contienen radicales organicos de silicio, proceso para su preparacion, y su empleo.
ZA807926B (en) Use of rosmarinic acid in the treatment of inflammations and pharmaceutical products used therein
ES2032582T3 (es) Procedimiento para preparar derivados de la oxima del 1,2,5,6,-tetrahidropiridin -3-carboxialdehido.
HN1999000067A (es) Preparados efervescentes
ES555837A0 (es) Un procedimiento para producir sulfatos de esteres de monoalquilo de glutationa
ES2062997T3 (es) Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
UY26517A1 (es) Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmacéuticas que las contienen, su uso como productos medicinales y procesos para prepararlas
ES2039465T3 (es) Un procedimiento para la purificacion de un alcohol isopropilico.
ZA802011B (en) New prostaglandin derivatives in the 6-keto-pge1 series
MX9300767A (es) Derivados del acido amidazolilpropenoico sustituidos por sulfonilbencilo, medicamentos que los contienen y procedimiento para la obtencion de tales medicamentos.
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
IT1094899B (it) 4-fenil-8-amino-tetraidroisochinoline,preparati farmaceutici contenenti tali sostanze,processo per la preparazione di questi preparati e loro impiego come antide pressivi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 255431

Country of ref document: ES